Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients

NCT06572553 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration
Diabetic Macular Edema
Retinal Vein Occlusion

Interventions

DRUG: Faricimab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University